Artificial intelligence and digital pathology: where are we now and what are the implementation barriers?

Benjamin Moxley-Wyles, Richard Colling
{"title":"Artificial intelligence and digital pathology: where are we now and what are the implementation barriers?","authors":"Benjamin Moxley-Wyles,&nbsp;Richard Colling","doi":"10.1016/j.mpdhp.2024.08.001","DOIUrl":null,"url":null,"abstract":"<div><div>Artificial intelligence (AI) has garnered significant public attention over the last few years and has become part of our everyday lives. This is no different in histopathology, with vast amounts of private and public sector investment into digital reporting and AI development. There are now several companies with commercially available AI decision support tools ready for adoption by pathologists in digitally mature laboratories. Many more pathology-oriented AI tools, with a variety of uses across the patient pathway, are on the horizon and include the possibility of multimodal integration. However, for AI in pathology to be used effectively and its benefits realized, there needs to be widespread ‘business as usual’ use of digital laboratory workflows and digital reporting. The NHS is currently undergoing a national pathology transformation programme that includes targets for digital reporting and AI ready capabilities for all laboratories in England. In this article, we provide an update on the current progress of AI development in histopathology including the AI tools currently available and potential future applications. We also discuss the ongoing implementation of digital pathology services in the NHS and highlight the barriers to building a strong foundation for AI tool deployment. This builds upon, and complements, our previous article on these issues.</div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"30 11","pages":"Pages 597-603"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic Histopathology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1756231724001294","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Artificial intelligence (AI) has garnered significant public attention over the last few years and has become part of our everyday lives. This is no different in histopathology, with vast amounts of private and public sector investment into digital reporting and AI development. There are now several companies with commercially available AI decision support tools ready for adoption by pathologists in digitally mature laboratories. Many more pathology-oriented AI tools, with a variety of uses across the patient pathway, are on the horizon and include the possibility of multimodal integration. However, for AI in pathology to be used effectively and its benefits realized, there needs to be widespread ‘business as usual’ use of digital laboratory workflows and digital reporting. The NHS is currently undergoing a national pathology transformation programme that includes targets for digital reporting and AI ready capabilities for all laboratories in England. In this article, we provide an update on the current progress of AI development in histopathology including the AI tools currently available and potential future applications. We also discuss the ongoing implementation of digital pathology services in the NHS and highlight the barriers to building a strong foundation for AI tool deployment. This builds upon, and complements, our previous article on these issues.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人工智能和数字病理学:我们现在处于什么阶段,有哪些实施障碍?
人工智能(AI)在过去几年中引起了公众的极大关注,并已成为我们日常生活的一部分。组织病理学也不例外,私营和公共部门对数字报告和人工智能开发进行了大量投资。目前已有多家公司推出了商业化的人工智能决策支持工具,可供数字化成熟实验室的病理学家采用。还有更多面向病理学的人工智能工具即将问世,这些工具在患者的整个病程中具有多种用途,并有可能实现多模态集成。然而,要想在病理学领域有效使用人工智能并实现其优势,就必须广泛 "照常 "使用数字化实验室工作流程和数字化报告。英国国家医疗服务体系(NHS)目前正在实施一项国家病理学转型计划,其中包括为英格兰所有实验室提供数字报告和人工智能就绪能力的目标。在本文中,我们将介绍组织病理学领域人工智能发展的最新进展,包括目前可用的人工智能工具和未来可能的应用。我们还讨论了英国国家医疗服务系统(NHS)正在实施的数字病理服务,并强调了为人工智能工具部署奠定坚实基础所面临的障碍。这篇文章是对我们之前有关这些问题的文章的补充和完善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Diagnostic Histopathology
Diagnostic Histopathology Medicine-Pathology and Forensic Medicine
CiteScore
1.30
自引率
0.00%
发文量
64
期刊介绍: This monthly review journal aims to provide the practising diagnostic pathologist and trainee pathologist with up-to-date reviews on histopathology and cytology and related technical advances. Each issue contains invited articles on a variety of topics from experts in the field and includes a mini-symposium exploring one subject in greater depth. Articles consist of system-based, disease-based reviews and advances in technology. They update the readers on day-to-day diagnostic work and keep them informed of important new developments. An additional feature is the short section devoted to hypotheses; these have been refereed. There is also a correspondence section.
期刊最新文献
Editorial board Malignant cutaneous clear cell tumours: a review of histological, immunohistochemical and molecular features Rare variants of mycosis fungoides: a practical approach with emphasis on differential diagnosis Undifferentiated round cell sarcomas of the skin Histopathological diagnosis of psoriasis and psoriasiform dermatitides
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1